Interactions between MTHFR C677T - A1298C variants and folic acid deficiency affect breast cancer risk in a Chinese population

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 2199-2206

  Wu, Xia Yu ^a,b   Ni, Juan ^b   Xu, Wei Jiang ^b   Zhou, Tao ^b   Wang, Xu ^a,b  

^a YUNNAN UNIVERSITY   (China)

^b YUNNAN NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Breast cancer; Combined MTHFR C677T A1298C; Folic acid; Genetic damage

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ARTICLE; BREAST TUMOR; CANCER STAGING; CASE CONTROL STUDY; CHINA; COMPARATIVE STUDY; FEMALE; FOLIC ACID DEFICIENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; FOLIC ACID DEFICIENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; RISK FACTORS;

EID: 84872685096     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.2199     Document Type: Article

References (43)

1. Andrew JV, Douglas GA (2001). Analysing controlled trials with baseline and follow up measurements. Brit Med J, 323, 1123-4.
2. Beilbya J, Ingramb D, Hahnelc R, Rossia E (2004). Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene. Eur J Cancer, 40, 1250-4.
3. Bistulfi G, Vandette E, Matsui S, Smiraglia DJ (2010). Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells. BMC Biol, 8, 6.
4. Bouckaert KP, Slimani N, Nicolas G, et al (2011). Critical evaluation of folate data in European and international databases: Recommendations for standardization in international nutritional studies. Mol Nutr Food Res, 55, 166-80.
5. Campbell IG, Baxter SW, Eccles DM, Choong DY (2002). Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res, 4, R14.
6. Celtikci B, Lawrance AK, Wu Q, Rozen R (2009). Methotrexate-induced apoptosis is enhanced by altered expression of methylenetetrahydrofolate reductase. Anticancer Drugs, 20, 787-93.
7. Crott JW, Mashiyama ST, Ames BN, Fenech M (2001). The effect of folic acid deficiency and MTHFR C677T polymorphism on chromosome damage in human lymphocytes in vitro. Cancer Epidemiol Biomarkers Prev, 10, 1089-96.
8. Dhillon V, Thomas P, Fenech M (2009). Effect of common polymorphisms in folate uptake and metabolism genes on frequency of micronucleated lymphocytes in a South Australian cohort. Mutat Res, 665, 1-6.
9. Eichholzer M, Tonz O, Zimmermann R (2006). Folic acid: a public-health challenge. Lancet, 367, 1352-61.
10. Everson RB, Wehr CM, Erexson GL, MacGregor JT (1988). Association of marginal folate depletion with increased human chromosomal damage in vivo: demonstration by analysis of micronucleated erythrocytes. J Natl Cancer Inst, 80, 525-9.
11. Fenech M, Crott JW (2002). Micronuclei, nucleoplasmic bridges and nuclear buds induced in folic acid deficient human lymphocytes-evidence for breakage- fusion-bridge cycles in the cytokinesis-block micronucleus assay. Mutat Res, 504, 131-6.
12. Fenech M (2006). Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res, 600, 58-66.
13. Fenech M (2001). The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat Res, 475, 56-67.
14. Friso S, Choi SW, Girelli D, et al (2002). A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate staus. Proc Natl Acad Sci USA, 99, 5606-11.
15. Guttenbach M, Schmid M (1994). Exclusion of specific human chromosomes into micronuclei by 5-azacytidine treatment in lymphocyte cultures. Exp Cell Res, 211, 127-32.
16. Huang L, Song X, Zhu W, Li Y (2008). Plasma homocysteine and gene polymorphisms associated with the risk of hyperlipidemia in northern Chinese subjects. Biomed Environ Sci, 21, 514-20.
17. Johnson J, Mejia de EG (2011). Dietary factors and pancreatic cancer. The role of food bioactive compounds. Mol Nutr Food Res, 55, 58-73.
18. Kim YI (1999). Folate and carcinogenesis: evidence, mechanisms and implications. J Nutr Biochem, 10, 66-8.
19. Kim YI, Baik HW, Fawaz K, et al (2001). Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial. Am J Gastroenterol, 96, 184-95.
20. Lin KW, Birmingham E (2010). Folic Acid for the prevention of neural tube defects. Am Fam Physician, 82, 1533.
21. Maruti SS, Ulrich CM, White E (2009). Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr, 89, 624-33.
22. Mazza D, Chapman A (2010). Improving the uptake of preconception care and periconceptional folate supplementation: what do women think. BMC Public Health, 23, 786.
23. Ni J, Lu L, Fenech M, Wang X (2010). Folate Deficiency in Human peripheral blood lymphocytes induces chromosome 8 aneuploidy but this effect is not modified by riboflavin.
24. Promthet SS, Pientong C, Ekalaksananan T, et al (2010). Risk factors for colon cancer in Northeastern Thailand: interaction of MTHFR codon 677 and 1298 genotypes with environmental factors. J Epidemiol, 20, 329-338.
25. Quinlivan EP, Davis SR, Shelnutt KP, et al (2005). Methylenetetrahydrofolate reductase 677CgT polymorphism and folate status affect one-carbon incorporation into human DNA deoxynucleosides. J Nutr, 135, 389-96.
26. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB (2000). Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr, 72, 998-1003.
27. Rodrigues JO, Galbiatti AL, Ruiz MT (2010). Polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene and risk of head and neck squamous cell carcinoma. Braz J Otorhinolaryngol, 76, 776-82.
28. Ruosaari ST, Nymark PE, Aavikko MM, et al (2008). Aberrations of chromosome 19 in asbestos-associated lung cancer and in asbestos-induced micronuclei of bronchial epithelial cells in vitro. Carcinogenesis, 29, 913-17.
29. Skibola CF, Smith MT, Hubbard A, et al (1999). Polymorphism in the methylene-tetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA, 96, 12810-5.
30. Song J, Geltinger C, Sun K, Kanazawa I, Yokoyama KK (1999). Direct lysis method for the rapid preparation of plasmid DNA. Anal Biochem, 271, 89-91.
31. Suleeporn S, Yasunori S, Hiromi S, et al (2010). Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women. Breast Cancer Res Treat, 123, 885-93.
32. Thomas P, Fenech M (2008). Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease. Mutagenesis, 23, 57-65.
33. Thomas P, Fenech M (2008). Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease. Vitam Horm, 79, 375-92.
34. Wang X, Thomas P, Xue J, Fenech M (2004). Folate deficiency induces aneuploidy in human lymphocytes in vitro-evidence using cytokinesis-blocked cells and probes specific for chromosomes 17 and 21. Mutation Res, 551, 167-80.
35. Wang X, Wu X, Liang Z, et al (2006). A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in Yunnan. Mutagenesis, 21, 41-7.
36. Wei Q, Shen H, Wang LE, et al (2003). Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol Biomarkers Prev, 12, 963-9.
37. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998). A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab, 64, 169-72.
38. Wu X, Liang Z, Zou T, Wang X (2009). Effects of folic acid deficiency and MTHFR C677T polymorphisms cytotoxicity in human peripheral blood lymphocytes. BBRC, 379, 732-7.
39. Xiao WL, Wu M, Shi B (2006). Folic acid rivals methylenetetrahydrofolate reductase (MTHFR) gene-silencing effect on MEPM cell proliferation and apoptosis. Mol Cell Biochem, 292, 145-54.
40. Xu GL, Bestor TH, Bourc'his D, et al (1999). Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature, 402, 187-91.
41. Yang QH, Botto LD, Gallagher M, et al (2008). Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr, 88, 232-46.
42. Yi P, Pogribny I, James JS (2002). Multiplex PCR for simultaneous detection of 677CgT and 1298AgC polymorphisms in methylenetetrahydrofolate reductase gene for population studies of cancer risk. Cancer Lett, 181, 209-13.
43. Zoodsma M, Nolte IM, Schipper M, et al (2005). Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease. Hum Genet, 116, 247-54.